CN114732770A - 一种应用于舒缓抗皮肤过敏化妆品的组合物 - Google Patents
一种应用于舒缓抗皮肤过敏化妆品的组合物 Download PDFInfo
- Publication number
- CN114732770A CN114732770A CN202210471305.5A CN202210471305A CN114732770A CN 114732770 A CN114732770 A CN 114732770A CN 202210471305 A CN202210471305 A CN 202210471305A CN 114732770 A CN114732770 A CN 114732770A
- Authority
- CN
- China
- Prior art keywords
- portions
- parts
- skin allergy
- cosmetics
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 13
- 241000205585 Aquilegia canadensis Species 0.000 claims description 9
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 6
- 244000042664 Matricaria chamomilla Species 0.000 claims description 6
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 6
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 6
- 240000006688 Telosma cordata Species 0.000 claims description 6
- 235000017352 Telosma cordata Nutrition 0.000 claims description 6
- 244000144927 Aloe barbadensis Species 0.000 claims description 5
- 235000002961 Aloe barbadensis Nutrition 0.000 claims description 5
- 240000002129 Malva sylvestris Species 0.000 claims description 5
- 235000006770 Malva sylvestris Nutrition 0.000 claims description 5
- 235000011399 aloe vera Nutrition 0.000 claims description 5
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 3
- 241000245665 Taraxacum Species 0.000 claims 4
- 244000170916 Paeonia officinalis Species 0.000 claims 2
- 235000006484 Paeonia officinalis Nutrition 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 8
- 230000035945 sensitivity Effects 0.000 abstract 2
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000003467 diminishing effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- XMKLTEGSALONPH-UHFFFAOYSA-N 1,2,4,5-tetrazinane-3,6-dione Chemical compound O=C1NNC(=O)NN1 XMKLTEGSALONPH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010064503 Excessive skin Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000001140 aloe barbadensis leaf extract Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Abstract
本发明涉及一种应用于舒缓抗皮肤过敏化妆品的组合物。其中含有母菊、欧蒲公英、库拉索芦荟、欧锦葵、芍药根、金银花、紫花地丁，均选用植物成分，将本组合物应用于化妆品中，利用植物的药用价值，可以有效作用于皮肤，舒缓皮肤敏感性，改善皮肤敏感问题，同时，成分均为天然物质，使用安全，无副作用，对皮肤的适应性强，可应用于不同化妆品中，具有较好的推广前景。
Description
技术领域
本发明涉及化妆品技术领域，具体为一种应用于舒缓抗皮肤过敏化妆品的组合物。
背景技术
皮肤作为人体最大的器官，具有防止体内水分、电解质等物质的丢失，以及阻止外界有害物质的入侵，保持人体内环境的稳定等作用，光滑、细致而富有弹性的皮肤是人们共同追求的目标。
由于环境的恶化，生活、工作压力的增大，以及过度的皮肤清洁，导致越来越多的人皮肤屏障受损，开始出现皮肤红斑、发痒、刺痛等炎性症状。同时，化妆品的不当使用，加重了这些症状。因此，人们迫切地需要具有明显抗炎效果、安全、无不良反应的化妆品来达到舒缓过敏症状的目的。
发明内容
鉴于现有技术中所存在的问题，本发明公开了一种应用于舒缓抗皮肤过敏化妆品的组合物，其主要成分及重量份配比为：
作为本发明的一种优选方案，母菊为一年生草本植物，具有祛风解表、清热解毒、止咳平喘、祛风湿的功效，同时具有消炎、解痉的作用。
作为本发明的一种优选方案，欧蒲公英具有消炎抗菌和调理肌肤的功效，使用安全且无副作用，无致豆性。
作为本发明的一种优选方案，库拉索芦荟叶中汁液，浓缩的干燥品，叶可以入药，性味苦，寒；清热，通便，杀虫；主治热结便秘，妇女经闭，小儿晾痫，疳热虫积，癣疮，痔瘘，萎缩性鼻炎，瘰疬。
作为本发明的一种优选方案，芍药根具有清热凉血，活血祛瘀的功效。主治热人营血，温毒发斑，吐血衄血，目赤肿痛，肝郁胁痛，经闭痛经，瘾瘕腹痛，跌扑损伤，痈肿疮疡。味苦，性微寒。归肝经。
作为本发明的一种优选方案，金银花，别名忍冬花、鹭鸶花、银花、双花、二花、金藤花、双苞花、金花、二宝花。具有清热解毒的功效。主治痈肿疔疮，喉痹，丹毒，热毒血痢，风热感冒，温病发热。味甘，性寒。归肺、胃经。
作为本发明的一种优选方案，紫花地丁具有清热解毒，消痈肿的功效。主治流行性感冒，上呼吸道感染，扁桃体炎，传染性肝炎，肠炎，痢疾，肾炎，腮腺炎，结膜炎，急性阑尾炎，疔疮痈肿，瘰疬。味苦；性寒。归心、脾经。
本发明的有益效果：本发明提供的一种应用于舒缓抗皮肤过敏化妆品的组合物，其中含有母菊、欧蒲公英、库拉索芦荟、欧锦葵、芍药根、金银花、紫花地丁，均选用植物成分，将本组合物应用于化妆品中，利用植物的药用价值，可以有效作用于皮肤，舒缓皮肤敏感性，改善皮肤敏感问题，同时，成分均为天然物质，使用安全，无副作用，对皮肤的适应性强，可应用于不同化妆品中，具有较好的推广前景。
具体实施方式
实施例1
本发明所述的一种应用于舒缓抗皮肤过敏化妆品的组合物，其主要成分及重量份配比为：
实施例2
本发明所述的一种应用于舒缓抗皮肤过敏化妆品的组合物，其主要成分及重量份配比为：
实施例3
本发明所述的一种应用于舒缓抗皮肤过敏化妆品的组合物，其主要成分及重量份配比为：
本文中未详细说明的部分为现有技术。
上述虽然对本发明的具体实施例作了详细说明，但是本发明并不限于上述实施例，在本领域普通技术人员所具备的知识范围内，还可以在不脱离本发明宗旨的前提下做出各种变化，而不具备创造性劳动的修改或变形仍在本发明的保护范围以内。
Claims (4)
1.一种应用于舒缓抗皮肤过敏化妆品的组合物，其特征在于，其主要成分及重量份配比为：母菊5-10份、欧蒲公英3-8份、库拉索芦荟15-20份、欧锦葵10-20份、芍药根5-10份、金银花20-30份、紫花地丁20-30份。
2.根据权利要求1所述的一种应用于舒缓抗皮肤过敏化妆品的组合物，其特征在于：由母菊5份、欧蒲公英3份、库拉索芦荟15份、欧锦葵10份、芍药根5份、金银花20份、紫花地丁20份组成。
3.根据权利要求1所述的一种应用于舒缓抗皮肤过敏化妆品的组合物，其特征在于：由母菊10份、欧蒲公英8份、库拉索芦荟20份、欧锦葵20份、芍药根10份、金银花30份、紫花地丁30份组成。
4.根据权利要求1所述的一种应用于舒缓抗皮肤过敏化妆品的组合物，其特征在于：由母菊8份、欧蒲公英6份、库拉索芦荟18份、欧锦葵15份、芍药根8份、金银花25份、紫花地丁25份组成。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210471305.5A CN114732770A (zh) | 2022-04-28 | 2022-04-28 | 一种应用于舒缓抗皮肤过敏化妆品的组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210471305.5A CN114732770A (zh) | 2022-04-28 | 2022-04-28 | 一种应用于舒缓抗皮肤过敏化妆品的组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114732770A true CN114732770A (zh) | 2022-07-12 |
Family
ID=82286480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210471305.5A Pending CN114732770A (zh) | 2022-04-28 | 2022-04-28 | 一种应用于舒缓抗皮肤过敏化妆品的组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114732770A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107737041A (zh) * | 2017-11-17 | 2018-02-27 | 珠海姗拉娜化妆品有限公司 | 一种新型皮肤抗敏修护组合物、皮肤修复霜及其制备方法 |
| CN109431928A (zh) * | 2018-11-19 | 2019-03-08 | 广州市皓雨化妆品有限公司 | 一种具有保湿、舒缓、美白功效的组合物与应用 |
-
2022
- 2022-04-28 CN CN202210471305.5A patent/CN114732770A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107737041A (zh) * | 2017-11-17 | 2018-02-27 | 珠海姗拉娜化妆品有限公司 | 一种新型皮肤抗敏修护组合物、皮肤修复霜及其制备方法 |
| CN109431928A (zh) * | 2018-11-19 | 2019-03-08 | 广州市皓雨化妆品有限公司 | 一种具有保湿、舒缓、美白功效的组合物与应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107349302B (zh) | 一种具有修复敏感皮肤功效的中药组合物及其发酵物与应用 | |
| CN109394959B (zh) | 一种具有修复皮肤角质层功效的中药组合物及其水提物和发酵物及应用 | |
| CN105030621A (zh) | 一种保湿祛痘爽肤水及其制备方法 | |
| KR102026535B1 (ko) | 생약 추출 혼합물을 포함하는 화장료 조성물 | |
| CN111700841A (zh) | 含黑灵芝植物提取物精华的防脱生发洗发露及其制备方法 | |
| CN111437326A (zh) | 一种用于避瘟防感的中药组合物及其外用制剂和应用 | |
| CN104857290A (zh) | 一种治疗烧烫伤的中药消毒膏及其制备方法 | |
| WO2012106990A1 (zh) | 一种治疗头癣的中药熏洗剂 | |
| KR100894439B1 (ko) | 아토피성 피부염의 예방 효과를 가지는 화장료 조성물 및 그 제조 방법 | |
| CN105030620A (zh) | 一种保湿祛痘洗面奶及其制备方法 | |
| CN111671882A (zh) | 一种用于增强免疫力的制剂及其制备装置和方法 | |
| CN114732770A (zh) | 一种应用于舒缓抗皮肤过敏化妆品的组合物 | |
| CN110652544A (zh) | 一种治疗鼻炎的药物组合物及其制备方法 | |
| CN105079420A (zh) | 一种用于创面的麻醉膏剂及其制备方法 | |
| CN108853448B (zh) | 一种治疗颈椎病的中药及其制备方法 | |
| WO2018090276A1 (zh) | 一种预防及治疗过敏性鼻炎哮喘综合症的中药组合物及其制备方法 | |
| CN105770796A (zh) | 一种治疗软组织损伤药酒搽剂 | |
| CN111658703A (zh) | 一种加快肺炎患者恢复的中药 | |
| CN109793849A (zh) | 一种祛痛保健贴 | |
| CN110227109B (zh) | 一种用于猪慢性湿疹的组合物及其制备方法 | |
| CN110812387A (zh) | 一种用于治疗湿毒疼痛的草本露及其制备方法 | |
| CN105055854A (zh) | 一种治疗神经性皮炎的中药 | |
| CN108837028A (zh) | 一种治疗皮肤病的软膏 | |
| CN105012775A (zh) | 一种治疗急性乳腺炎的中药 | |
| CN112972356A (zh) | 一种中药护肤组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220712 |